(1) The department and consortium members may solicit and accept gifts, grants, and donations of any kind received from sources other than the state for purposes of funding the drug development clinical trial under this chapter.
(2) Disbursements of funds by the department may be made incrementally based on the completion of clearly defined objectives as negotiated in the contract described by Section 41-155-13, including verifiable documentation demonstrating the efficient expenditure of both state and matching funds.